Novel Anticancer Drug Protocols

Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Buolamwini, John K. (Editor ), Adjei, Alex A. (Editor )
Formato: eBook
Lenguaje:English
Publicado: Totowa, NJ : Humana Press : Imprint: Humana, 2003.
Edición:1st ed. 2003.
Colección:Methods in Molecular Medicine, 85
Materias:
Acceso en línea:https://doi.org/10.1385/1592593801
LEADER 03149nam a22003015i 4500
001 978-1-59259-380-4
005 20190618101626.0
007 cr nn 008mamaa
008 100301s2003 xxu| s |||| 0|eng d
020 |a 9781592593804 
024 7 |a 10.1385/1592593801  |2 doi 
040 |a Sistema de Bibliotecas del Tecnológico de Costa Rica 
245 1 0 |a Novel Anticancer Drug Protocols  |c edited by John K. Buolamwini, Alex A. Adjei. 
250 |a 1st ed. 2003. 
260 # # |a Totowa, NJ :  |b Humana Press :  |b Imprint: Humana,  |c 2003. 
300 |a XVI, 355 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Methods in Molecular Medicine,  |v 85 
505 0 |a Overview of Novel Anticancer Drug Targets -- Kinase Inhibitor Discovery Protocols -- Biomarker Assays for Phosphorylated MAP Kinase -- Assays for Cyclin-Dependent Kinase Inhibitors -- Identifying Inhibitors of ATM and ATR Kinase Activities -- Angiogenesis and Metastasis Protocols -- The Rat Aortic Ring Assay for In Vitro Study of Angiogenesis -- Real Time In Vivo Quantitation of Tumor Angiogenesis -- Use of Tumor-Activated Hepatic Stellate Cell as a Target for the Preclinical Testing of Anti-Angiogenic Drugs Against Hepatic Tumor Development -- Cell Motility, Adhesion, Homing, and Migration Assays in the Studies of Tyrosine Kinases -- Inflammatory Response of Tumor-Activated Hepatic Sinusoidal Endothelium as a Target for the Screening of Metastasis Chemopreventive Drugs -- Binding Assay for Selectins -- Determination of Peak Serum Levels and Immune Response to the Humanized Anti-Ganglioside Antibody-Interleukin-2 Immunocytokine -- Immunohistochemical Assays in the Clinical Setting -- Immunohistochemical Determination of EGFR-Tyrosine Kinase Inhibition in Clinical Samples -- Immunohistochemical Assays of Farnesyltransferase Inhibition in Patient Samples -- Protein Chaperoning/Degradation Protocols -- Assays for HSP90 and Inhibitors -- Assays for Proteasome Inhibition -- Protein-Protein and Protein-DNA Interactions -- The Mammalian Two-Hybrid Assay for Detection of Coactivator-Nuclear Receptor Interactions -- Preparation of DNA-Protein Complexes Suitable for Spectroscopic Analysis -- Antisense -- Antisense Oligonucleotide Inhibitors of MDM2 Oncogene Expression -- Genomics -- Pharmacogenetic Analysis of Clinically Relevant Genetic Polymorphisms -- Gene Expression Microarrays -- Methods for Isolation and Genetic Analysis of Circulating Tumor DNA in Patient Plasma -- Cell Lifespan/Longevity -- The Use of Early Sea Urchin Embryos in Anticancer Drug Testing -- In Vivo Imaging -- PET Screening of Anticancer Drugs -- Miscellaneous Protocols -- Assays for In Vitro and In Vivo Synergy -- Flow Cytometric Methods for Detection and Quantification of Apoptosis -- Assays for Neoplastic Cell Enrichment in Bone Marrow Samples. 
650 0 |a Pharmacy. 
650 1 4 |a Pharmacy. 
700 1 |a Buolamwini, John K.  |e editor. 
700 1 |a Adjei, Alex A.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
856 4 0 |u https://doi.org/10.1385/1592593801